Kovack Advisors, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Kovack Advisors, Inc.

$907 Million
Q1 2025

A detailed history of Kovack Advisors, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Kovack Advisors, Inc. holds 5,359 shares of XBI stock, worth $424,379. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,359

Previous 6,146 12.81%

Holding current value

$424,379

Previous $553,000 21.52%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$81.1 - $94.7 $63,825 - $74,528	-787 Reduced 12.81%	5,359 $434,000
Q4 2024 Feb 04, 2025	BUY	$89.81 - $104.0 $143,426 - $166,088	1,597 Added 35.11%	6,146 $553,000
Q3 2024 Nov 05, 2024	SELL	$90.87 - $102.43 $64,063 - $72,213	-705 Reduced 13.42%	4,549 $449,000
Q2 2024 Aug 02, 2024	BUY	$82.22 - $94.12 $106,228 - $121,603	1,292 Added 32.61%	5,254 $487,000
Q1 2024 Apr 19, 2024	SELL	$87.05 - $102.89 $196,471 - $232,222	-2,257 Reduced 36.29%	3,962 $375,000
Q4 2023 Feb 02, 2024	SELL	$64.12 - $90.86 $642,803 - $910,871	-10,025 Reduced 61.72%	6,219 $555,000
Q3 2023 Oct 19, 2023	BUY	$71.88 - $85.76 $102,213 - $121,950	1,422 Added 9.59%	16,244 $1.19 Million
Q2 2023 Jul 21, 2023	BUY	$75.38 - $90.23 $859,633 - $1.03 Million	11,404 Added 333.65%	14,822 $1.23 Million
Q1 2023 Apr 20, 2023	BUY	$73.13 - $91.97 $249,958 - $314,353	3,418 New	3,418 $260,000
Q2 2022 Aug 10, 2022	BUY	$62.81 - $96.09 $697,944 - $1.07 Million	11,112 New	11,112 $825,000
Q1 2017 Sep 05, 2018	SELL	N/A	-3,667 Closed	0 $0
Q4 2016 Sep 10, 2018	BUY	N/A	3,667	3,667 $217,000

Others Institutions Holding XBI

# of Institutions

847

Shares Held

109M

Call Options Held

17.7M

Put Options Held

28.5M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History